The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The new drug, sold under the name Victoza and made by Hikma Pharmaceuticals USA Inc., follows the approval of the generic GLP ...
The UK's first safe drug consumption facility was due to open in October, but has been pushed back. A man and a woman were arrested after hundreds of thousands of pounds worth of the drug were found.
Dexamethasone oral tablet is a generic drug that’s prescribed for many conditions, including allergic reactions and inflammation. Dexamethasone belongs to a class of drugs called corticosteroids ...
Since Viagra is a brand-name medication, the price of Viagra is very high and may not currently fit within your budget. But a generic version (and the active ingredient) of this popular medication ...
For Sesame Care’s ED treatments, the company offers Tadalafil — the generic version of the brand name Cialis — and sildenafil, the generic version of the brand Viagra. The company states ...
Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. Drug overdose deaths in the United States fell by an estimated 14.5 percent from June 2023 to June 2024 ...
LOS ANGELES—America’s drug crisis has many survivors. Jerry Schlesinger, 72, is among the longest tenured. He tried heroin at 15. Today, he has been sober for two years. In between ...
How common do you think your current favorite baby name is? Parenting website BabyCenter ranked the top 100 most popular baby names for the year of 2024 this past October. According to their ...
In the 1990s, overprescribing by doctors, along with aggressive and deceptive drug marketing by pharmaceutical companies, led to a deadly and ongoing opioid epidemic that has killed more than ...
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. By Rebecca Robbins Christina Jewett ...